Oral hyoscine butylbromide exerts spasmolytic effects in both gastrointestinal and urogenital tissues in rats
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.17474 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Sara Traserra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Physiology and Immunology and Neurosciences Institute, Universitat Autònoma de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Parasympatholytics, Butylscopolammonium Bromide, Urinary Bladder, Uterus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi.
Abstract (Originalsprache)
Background and Purpose Hyoscine butylbromide (HBB) has a low oral (PO) bioavailability. Further, limited data on its activity on non‐gastrointestinal (GI) smooth muscle spasms after oral dosing are available, causing its effects beyond the GI tract to be questioned. This pharmacokinetic/pharmacodynamic (PK/PD) study, conducted using female rats, aimed to cover this gap. Experimental Approach PK study: HBB and atropine (as a comparator agent) were administered PO and IV to rats, and concentrations in plasma and tissues (colon, uterus and urinary bladder; CUB) were measured. PD study 1: concentration–response curves of HBB and atropine (10 −9 –10 −4 M) were obtained for carbachol‐induced (10 −5 M) pre‐contracted tissues; PD study 2: CUB were pre‐incubated with HBB and atropine at maximum concentrations ( C max ) from PK studies and carbachol concentration–response curves (10 −9 –10 −4 M) were obtained; PD study 3: HBB and atropine were administered PO and IV to rats as for PK study, CUB tissues were collected at 0.5 h (IV) and 4 h (PO), and carbachol concentration–response curves (10 −9 –10 −4 M) obtained. Key Results PO HBB showed higher C max in CUB tissues than in plasma. HBB and atropine reduced, concentration‐dependently, carbachol‐induced contractions in CUB tissues. PO HBB showed highest spasmolytic activity in colon (40%), followed by uterus (30%) and urinary bladder (10%). Conclusion and Implications This is the first comparison of PO and IV HBB and atropine in GI and non‐GI tissues. Despite low bioavailability, PO HBB accumulated and exerted spasmolytic effects in tissues beyond the GI tract.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Physiology and Immunology and Neurosciences Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Sanofi, Neuilly-sur-Seine, France.
- Sanofi, Frankfurt am Main, Germany.
- NIHR Nottingham BRC, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
- Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
ORCID-Profile: Marcel Jimenez
Förderung
- Sanofi
Zitieren
APA
Traserra, S., Appelqvist, T., Lange, R., Corsetti, M., & Jimenez, M. (2025). Oral hyoscine butylbromide exerts spasmolytic effects in both gastrointestinal and urogenital tissues in rats. British Journal of Pharmacology. https://doi.org/10.1111/bph.17474
Vancouver
Traserra S, Appelqvist T, Lange R, Corsetti M, Jimenez M. Oral hyoscine butylbromide exerts spasmolytic effects in both gastrointestinal and urogenital tissues in rats. British Journal of Pharmacology. 2025. doi:10.1111/bph.17474
BibTeX
@article{Traserra2025,
author = {Traserra, Sara and Appelqvist, Terence and Lange, Robert and Corsetti, Maura and Jimenez, Marcel},
title = {Oral hyoscine butylbromide exerts spasmolytic effects in both gastrointestinal and urogenital tissues in rats},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.17474}
}
EUVIMED